NAFLD: the silent epidemic
Non-alcoholic fatty liver disease (NAFLD) affects 25% of the world's population — in Belgium ~1.5 million people. Progression: steatosis (fat accumulation) → NASH (steatohepatitis, inflammation) → fibrosis → cirrhosis → hepatocellular carcinoma. The main dietary cause: excessive fructose, because only the liver can metabolize it.
Hepatic mechanisms of ginger
1. AMPK activation in the liver
AMPK is the cellular "energy sensor". In the liver, activated AMPK brings about:
- Phosphorylation of ACC → ↓ malonyl-CoA → ↓ CPT1 inhibition → ↑ mitochondrial fatty acid oxidation
- Inhibition of SREBP-1c → ↓ de novo lipogenesis (FAS, ACC, SCD-1)
- Stimulation of lipophagy → breakdown of lipid droplets
6-Gingerol directly activates AMPK via increased AMP/ATP ratio and LKB1 in hepatocytes. Result: less fat accumulation in the liver.
2. SREBP-1c inhibition
SREBP-1c activates lipogenesis genes: FAS, ACC, SCD-1. Activated by insulin and fructose. Ginger inhibits SREBP-1c via AMPK (phosphorylation → SREBP-1c degradation) and NF-κB inhibition. Result: -20 to -35% liver triglycerides in NAFLD models.
3. NF-κB inhibition in hepatocytes (NASH)
Progression from NAFLD to NASH is mediated by NF-κB → TNF-α, IL-6, IL-1β → lobular liver inflammation → stellate cell activation → fibrosis. Ginger inhibits NF-κB and reduces hepatic TNF-α, slowing progression to NASH.
4. Nrf2/HO-1 protection against oxidative stress
NAFLD generates massive hepatic oxidative stress (mitochondrial ROS + fructose-induced XO activation). Ginger activates Nrf2 → NQO1, HO-1, GPx → less hepatocyte ROS → less lipoperoxidation → protection of the mitochondrial membrane.
5. Improvement of insulin resistance
Liver fat is causally linked to insulin resistance. Ginger improves IRS-1/PI3K/Akt signaling in hepatocytes → less gluconeogenesis and better glucose uptake → less hyperinsulinemia that fuels lipogenesis.
| Target | Ginger effect | Hepatic consequence |
|---|---|---|
| AMPK | Direct activation | ↑ β-oxidation + ↓ lipogenesis |
| SREBP-1c | Transcriptional inhibition | ↓ FAS, ACC → -20-35% liver triglycerides |
| NF-κB | Inhibition → ↓ TNF-α, IL-6 | ↓ inflammation → slows NASH |
| IRS-1/Akt | Signaling improvement | ↓ hepatic insulin resistance |
| Nrf2/HO-1 | Antioxidant activation | ↓ oxidative stress + lipoperoxidation |
GIMBER fructose: direct cause of NAFLD
GIMBER contains ~35g sucrose/100ml = ~17.5g fructose/100ml:
- Fructose → fructokinase → fructose-1-phosphate → DHAP + glyceraldehyde → acetyl-CoA → FAS → liver triglycerides
- Unlike glucose, fructose escapes regulation by insulin and glucokinase → massive, unregulated liver uptake
- One GIMBER shot (30ml) = ~5.25g fructose → direct hepatic lipogenesis in 30 minutes
- Causal correlation: the rise in fructose consumption (soft drinks, juices) is the main cause of the NAFLD epidemic
Clinical studies: ginger and liver
| Study | Population | Dose | Result |
|---|---|---|---|
| Rahimlou 2016 | NAFLD (n=44) | 2g/day ginger 12 wk | ALT ↓ 21%, ginger HOMA-IR ↓ 19%, TNF-α ↓ 25% |
| Mirmiran 2016 | T2DM + NAFLD | 3g/day 12 wk | TG ↓, VLDL ↓, LDL-ox ↓ |
| Shirpoor 2015 | Rat NAFLD model | Ginger extract | SREBP-1c ↓ 40%, FAS ↓ 35%, Nrf2 ↑ |
❓ FAQ — Ginger and fatty liver
Q: Can ginger reverse NAFLD?
A: In early stages (simple steatosis), a combination of dietary adjustments (fructose elimination), exercise, and ginger can reduce liver fat. Advanced NAFLD (fibrosis, NASH) requires medical guidance.
Q: Is GIMBER harmful to the liver?
A: Regularly consumed, GIMBER delivers significant amounts of fructose (~5.25g/shot). In the long term, combined with other fructose sources, this can contribute to fatty liver disease in at-risk groups (overweight, insulin resistance).
Q: What ginger dose for liver health?
A: Clinical studies use 2-3g/day of standardized extract for 12 weeks. INTI (artisanally prepared organic ginger) provides active gingerols without added fructose.
Related articles
Read more about related topics :
- Ginger and Fatty Liver (NAFLD): INTI Protects, GIMBER (35g Sugar) Worsens
- Ginger and Liver: Fatty Liver (NAFLD), Detoxification and Protection
- Ginger and Fatty Liver (NAFLD/NASH): Reducing Liver Fat and Controlling Inflammation
- Fatty Liver (NAFLD) in Belgium: Sugary Drinks, Fructose, and Ginger as a Hepatoprotector
- INTI and Fatty Liver (NAFLD/NASH): How Fructose from Soft Drinks Damages the Liver and Ginger Protects It
- Ginger and NASH: Non-Alcoholic Fatty Liver Disease, Transaminases & Inflammation
- INTI and Gout: The Fructose→Uric Acid Mechanism That Your Drinks Hide in Belgium
- Ginger and Digestive Cancers: Colon, Stomach, and Pancreas — NF-κB Tumoral, Apoptosis, and AMPK/mTORC1 — INTI